N. Girerd, P. Rossignol, and F. Zannad, Fibrinolysis for intermediate-risk pulmonary embolism, N Engl J Med, vol.371, issue.6, p.579, 2014.

J. Ferreira, S. Coiro, and N. Girerd, A Systematic Assessment of Absolute Treatment Effect, The American Journal of Cardiology, vol.116, issue.5, pp.829-860, 2015.
DOI : 10.1016/j.amjcard.2015.07.023

URL : https://hal.archives-ouvertes.fr/hal-01740784

S. Coiro, P. Ferreira, J. Ambrosio, G. Zannad, F. Girerd et al., To the Editor??? Diabetes and sudden death: Let???s assess the absolute risk increase rather than the proportional risk from sudden cardiac death!, Heart Rhythm, vol.12, issue.11, p.138, 2015.
DOI : 10.1016/j.hrthm.2015.08.008

URL : https://hal.archives-ouvertes.fr/hal-01758773

N. Girerd, T. Collier, S. Pocock, H. Krum, J. Mcmurray et al., Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial, European Heart Journal, vol.36, issue.34, pp.2310-2317, 2015.
DOI : 10.1093/eurjhf/hft100

URL : https://hal.archives-ouvertes.fr/hal-01742988

N. Girerd, F. Zannad, and P. Rossignol, Review of heart failure treatment in type??2 diabetes patients: It's at least as effective as in non-diabetic patients!, Diabetes & Metabolism, vol.41, issue.6, pp.446-55, 2015.
DOI : 10.1016/j.diabet.2015.06.004

D. Suissa, P. Brassard, B. Smiechowski, and S. Suissa, Number needed to treat is incorrect without proper time-related considerations, Journal of Clinical Epidemiology, vol.65, issue.1, pp.42-48, 2011.
DOI : 10.1016/j.jclinepi.2011.04.009

N. Girerd, J. Magne, M. Rabilloud, E. Charbonneau, S. Mohamadi et al., The Impact of Complete Revascularization on Long-Term Survival Is Strongly Dependent on Age, The Annals of Thoracic Surgery, vol.94, issue.4, pp.1166-72, 2012.
DOI : 10.1016/j.athoracsur.2012.05.023

S. Mohammadi, F. Dagenais, D. Doyle, P. Mathieu, R. Baillot et al., Age cut-off for the loss of benefit from bilateral internal thoracic artery grafting???, European Journal of Cardio-Thoracic Surgery, vol.33, issue.6, pp.977-82, 2008.
DOI : 10.1016/j.ejcts.2008.03.026

S. Mohammadi, D. Kalavrouziotis, F. Dagenais, P. Voisine, and E. Charbonneau, Completeness of Revascularization and Survival Among Octogenarians With Triple-Vessel Disease, The Annals of Thoracic Surgery, vol.93, issue.5, p.22480392, 2012.
DOI : 10.1016/j.athoracsur.2012.02.033

N. Rod, T. Lange, I. Andersen, J. Marott, and F. Diderichsen, Additive Interaction in Survival Analysis, Epidemiology, vol.23, issue.5, pp.733-740, 2012.
DOI : 10.1097/EDE.0b013e31825fa218

H. Nordahl, N. Rod, B. Frederiksen, I. Andersen, T. Lange et al., Education and risk of coronary heart disease: assessment of mediation by behavioral risk factors using the additive hazards model, European Journal of Epidemiology, vol.30, issue.2, pp.149-57, 2013.
DOI : 10.1093/ije/30.2.248

S. Giolo, J. Krieger, A. Mansur, and A. Pereira, Survival Analysis of Patients with Heart Failure: Implications of Time-Varying Regression Effects in Modeling Mortality, PLoS ONE, vol.56, issue.1, p.22715367, 2012.
DOI : 10.1371/journal.pone.0037392.t005

A. Abadi, S. Saadat, P. Yavari, C. Bajdik, and P. Jalili, Comparison of Aalen's additive and Cox proportional hazards models for breast cancer survival: analysis of population-based data from British Columbia, Canada. Asian Pac J Cancer Prev, vol.12, issue.11, pp.3113-3119, 2011.

T. Martinussen and T. Scheike, The additive hazards model with high-dimensional regressors, Lifetime Data Analysis, vol.12, issue.3, pp.330-372, 2009.
DOI : 10.1093/bioinformatics/18.suppl_1.S120

D. Altman and P. Andersen, Calculating the number needed to treat for trials where the outcome is time to an event, BMJ, vol.319, issue.7223, pp.1492-1497, 1999.
DOI : 10.1136/bmj.319.7223.1492

N. Girerd, M. Rabilloud, K. Duarte, and P. Roy, Number needed to treat from absolute risk and incidence rate: How to make apples and oranges comparable?, Journal of Clinical Epidemiology, vol.67, issue.2, pp.236-244, 2014.
DOI : 10.1016/j.jclinepi.2013.08.010

P. Austin, Absolute risk reductions and numbers needed to treat can be obtained from adjusted survival models for time-to-event outcomes, Journal of Clinical Epidemiology, vol.63, issue.1, pp.46-55, 2010.
DOI : 10.1016/j.jclinepi.2009.03.012

P. Austin, The performance of different propensity score methods for estimating marginal hazard ratios, Statistics in Medicine, vol.11, issue.3, pp.2837-2886, 2013.
DOI : 10.1002/pst.537

P. Austin, The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments, Statistics in Medicine, vol.61, issue.3, pp.1242-58, 2014.
DOI : 10.1111/j.1541-0420.2005.00356.x

A. Barratt, P. Wyer, R. Hatala, T. Mcginn, A. Dans et al., Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat, Canadian Medical Association Journal, vol.171, issue.4, pp.353-361, 2004.
DOI : 10.1503/cmaj.1021197

G. Gigerenzer, O. Wegwarth, and M. Feufel, Misleading communication of risk, BMJ, vol.341, issue.oct12 2, p.20940219, 2010.
DOI : 10.1136/bmj.c4830

N. King, S. Harper, and M. Young, Use of relative and absolute effect measures in reporting health inequalities: structured review, BMJ, vol.345, issue.sep03 1, p.22945952, 2012.
DOI : 10.1136/bmj.e5774

K. Schulz, D. Altman, D. Moher, and C. Group, CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, BMJ, vol.340, p.20332509, 2010.

E. Von-elm, D. Altman, M. Egger, S. Pocock, P. Gotzsche et al., The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement, Epidemiology, vol.18, issue.6, pp.344-353, 2008.
DOI : 10.1097/EDE.0b013e3181577654

M. Knol, I. Van-der-tweel, D. Grobbee, M. Numans, and M. Geerlings, Estimating interaction on an additive scale between continuous determinants in a logistic regression model, International Journal of Epidemiology, vol.20, issue.5, pp.1111-1119, 2007.
DOI : 10.1007/s10654-004-5689-2

M. Knol and T. Vanderweele, Recommendations for presenting analyses of effect modification and interaction, International Journal of Epidemiology, vol.174, issue.2, pp.514-534, 2012.
DOI : 10.1093/aje/kwr334

R. Venekamp, M. Rovers, A. Hoes, and M. Knol, Subgroup analysis in randomized controlled trials appeared to be dependent on whether relative or absolute effect measures were used, Journal of Clinical Epidemiology, vol.67, issue.4, pp.410-415, 2014.
DOI : 10.1016/j.jclinepi.2013.11.003

I. Gram, S. Sandin, T. Braaten, E. Lund, and E. Weiderpass, The hazards of death by smoking in middle-aged women, European Journal of Epidemiology, vol.3, issue.10, pp.799-806, 2013.
DOI : 10.2147/CLEP.S22681

K. Blix, S. Braekkan, S. Le-cessie, F. Skjeldestad, S. Cannegieter et al., The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Troms?? study, European Journal of Epidemiology, vol.163, issue.5, pp.277-84, 2014.
DOI : 10.1111/bjh.12575

M. Knol and T. Vanderweele, Recoding preventive exposures to get valid measures of interaction on an additive scale, European Journal of Epidemiology, vol.26, issue.10, pp.825-831, 2011.
DOI : 10.1007/s10654-011-9613-2

M. Knol, T. Vanderweele, R. Groenwold, O. Klungel, M. Rovers et al., Estimating measures of interaction on an additive scale for preventive exposures, European Journal of Epidemiology, vol.168, issue.6, pp.433-441, 2011.
DOI : 10.1093/aje/kwn104

URL : https://hal.archives-ouvertes.fr/hal-00673202

S. Coughlin, C. Nass, L. Pickle, B. Trock, and G. Bunin, Regression Methods for Estimating Attributable Risk in Population-based Case-Control Studies: A Comparison of Additive and Multiplicative Models, American Journal of Epidemiology, vol.133, issue.3, pp.305-318, 1991.
DOI : 10.1093/oxfordjournals.aje.a115875

C. Schmid, J. Lau, M. Mcintosh, and J. Cappelleri, An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials, Statistics in Medicine, vol.17, issue.17, pp.1923-1965, 1998.
DOI : 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6

F. Spencer, A. Iorio, J. You, M. Murad, H. Schunemann et al., Uncertainties in baseline risk estimates and confidence in treatment effects, BMJ, vol.345, issue.nov14 1, p.23152569, 2012.
DOI : 10.1136/bmj.e7401

A. Hingorani, D. Windt, R. Riley, K. Abrams, K. Moons et al., Prognosis research strategy (PROGRESS) 4: Stratified medicine research, BMJ, vol.346, issue.feb05 1, p.23386361, 2013.
DOI : 10.1136/bmj.e5793

URL : http://www.bmj.com/content/bmj/346/bmj.e5793.full.pdf

S. Hopewell, P. Ravaud, G. Baron, and I. Boutron, Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis, BMJ, vol.344, issue.jun22 1, p.22730543, 2012.
DOI : 10.1136/bmj.e4178

L. Schwartz, S. Woloshin, E. Dvorin, and H. Welch, Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks, BMJ, vol.333, issue.7581, pp.1248-17060338, 2006.
DOI : 10.1136/bmj.38985.564317.7C